Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001897612-25-000181
Filing Date
2025-05-14
Accepted
2025-05-14 10:47:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5885
  Complete submission text file 0001897612-25-000181.txt   7544
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 7818487100
HAEMONETICS CORP (Subject) CIK: 0000313143 (see all company filings)

EIN.: 042882273 | State of Incorp.: MA | Fiscal Year End: 0329
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-48277 | Film No.: 25943450
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1307 POINT STREET BALTIMORE MD 21231
Business Address 1307 POINT STREET BALTIMORE MD 21231 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A